Bank of America
DNA icon

Bank of America’s Ginkgo Bioworks DNA Stock Holding History

Bank of America’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92M Sell
476,913
-125,663
-21% -$1.05M ﹤0.01% 3850
2025
Q4 		$5.01M Sell
602,576
-465,999
-44% -$5.02M ﹤0.01% 3393
2025
Q3 		$15.6M Sell
1,068,575
-138,572
-11% -$1.66M ﹤0.01% 2846
2025
Q2 		$13.6M Buy
1,207,147
+199,813
+20% +$1.55M ﹤0.01% 2940
2025
Q1 		$5.74M Sell
1,007,334
-2,757,121
-73% -$28.1M ﹤0.01% 3670
2024
Q4 		$37M Buy
3,764,455
+3,336,964
+781% +$28.6M ﹤0.01% 1757
2024
Q3 		$3.48M Buy
427,491
+358,770
+522% +$3.59M ﹤0.01% 4074
2024
Q2 		$918K Sell
68,721
-9,210
-12% -$275K ﹤0.01% 4956
2024
Q1 		$3.62M Buy
77,931
+15,478
+25% +$801K ﹤0.01% 3934
2023
Q4 		$4.22M Sell
62,453
-4,894
-7% -$300K ﹤0.01% 3686
2023
Q3 		$4.88M Buy
67,347
+1,521
+2% +$122K ﹤0.01% 3431
2023
Q2 		$4.9M Buy
65,826
+2,906
+5% +$172K ﹤0.01% 3430
2023
Q1 		$3.35M Buy
62,920
+7,459
+13% +$473K ﹤0.01% 3908
2022
Q4 		$3.75M Sell
55,461
-14,747
-21% -$1.36M ﹤0.01% 3668
2022
Q3 		$8.76M Buy
70,208
+15,141
+27% +$1.8M ﹤0.01% 2747
2022
Q2 		$5.24M Sell
55,067
-11,406
-17% -$1.39M ﹤0.01% 3335
2022
Q1 		$10.7M Buy
66,473
+36,878
+125% +$7.18M ﹤0.01% 2800
2021
Q4 		$9.84M Buy
29,595
+27,414
+1,257% +$13M ﹤0.01% 2950
2021
Q3 		$1.01M Buy
+2,181
New +$1.06M ﹤0.01% 5056

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's DNA Position: Q1 2026 in Review

Bank of America reduced its Ginkgo Bioworks (DNA) stake by 21% in Q1 2026, selling an estimated $1.05M and leaving 476,913 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

Bank of America first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $37M in Q4 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Bank of America held 476,913 shares of Ginkgo Bioworks worth $2.92M as of Q1 2026.
  • Bank of America sold 125,663 Ginkgo Bioworks shares in Q1 2026, an estimated $1.05M.
  • Ginkgo Bioworks made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3850 holding.
  • Bank of America first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Ginkgo Bioworks position peaked at $37M in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.